Envista Holdings Gains After JPMorgan Upgrade to Overweight

Shares of Envista Holdings Corp. (NYSE:NVST) rose in premarket trading on Thursday after JPMorgan upgraded the stock, citing improved fundamentals and an attractive valuation ahead of the company's upcoming investor event.

JPMorgan Lifts Rating and Price Target

JPMorgan analyst Lilia-Celine B Lozada upgraded Envista Holdings to Overweight from a previous Neutral rating. The firm also raised its price target on the stock to $32.00, up from $29.00.

Following the announcement, Envista's shares climbed 2.3% in premarket trading. The upgrade comes just ahead of the company's Investor Day, scheduled for September 17th.

Improved Growth Outlook

The analyst's positive outlook is based on a belief that Envista is operating from a position of strength. In a note to clients, Lozada highlighted "improved execution, a more durable organic growth algorithm, and a valuation that has not fully kept pace with strengthening fundamentals."

Ad

JPMorgan anticipates that Envista's management will present a medium-term core growth framework that is higher than its prior 2-4% range, potentially reaching 2.5-4.5% or 3-4%. The bank believes Envista is positioned to maintain mid-single-digit growth by gaining market share in high-growth areas like dental implants and clear aligners.

Macro Headwinds Remain a Factor

While optimistic, JPMorgan acknowledged that macroeconomic conditions are the primary risk for the dental sector, which relies on consumer confidence and discretionary spending. However, the report noted that Envista has executed better than anticipated amid recent uncertainty.

The analyst concluded that demand has proven "more resilient than feared" and that Envista merits a higher valuation multiple if it continues to demonstrate a durable growth profile.